Condition: Eye Care · Nursing Care · Intensive Care Unit · Sponsor: Istanbul Saglik Bilimleri University
This study was designed as a prospective, randomized controlled experimental study aiming to compare different approaches to eye care in intensive care patients receiving mechanical ventilation. In this study, patients receiving mechanical ventilation in the intensive care unit will be randomly assigned to four groups using a simple randomization method: 1. Control Group: Standard Eye Care 2. Intervention Group 1: Eye Care with Eye Care Kit 3. Intervention Group 2: Eye Care According to Eye Care Protocol 4. Intervention Group 3: Eye Care with Both Protocol and Eye Care Kit Research Hypotheses H1: Eye care provided using a care protocol is more effective in preventing the development of complications compared to standard eye care. H2: Eye care provided using an eye care kit is more effective in preventing the development of ocular complications compared to standard eye care. H3: The combined use of an eye care kit and a care protocol is more effective in preventing the development of ocular complications compared to using the care protocol alone. H4: The use of an eye care kit is more effective in preventing the development of ocular complications compared to the use of a care protocol.
This description comes directly from the study's public registry record.
Yildiz Deniz · +905387251394 · yildizdeniz142@gmail.com
Besey Oren · +905327756206 · Besey.oren@sbu.edu.tr
Always discuss trial participation with your own doctor first.
| University of Health Sciences (Sağlık Bilimleri Üniversitesi) | Istanbul, Istanbul, Turkey (Türkiye) | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07070843